Join Our Mailing List:
Follow Us:
Shop Contact Us
You have 0  Item in Cart | View Cart
Featured Events
Thursday, February 18
24th Annual Research Awards Dinner
Experience one of the most meaningful STOP CANCER events of the year... 24th Annual Research Awards Dinner ... More
Tuesday, April 12
Educational Forum and Dinner at USC Norris
Educational Forum and Dinner at USC Norris ... More
View All Events
Ching-Cheng Chen, Ph.D.
Research performed at: City of Hope Comprehensive Cancer Center
Specialty/Research Area: Stem Cell, Leukemia
Award Year: 2013

Career Summary: Dr. Chen is Assistant Professor, Division of hematopoietic stem cell and leukemia Research, Beckman Research Institute of City of Hope (Duarte, CA) He received his Ph.D. in immunology in 2001 from the University of Alabama at Birmingham, followed by a two year postdoctoral fellowship there (2001 -2003). From 2003 – 2009, he undertook a second postdoctoral fellowship at the Stanford University (Stanford, CA). He was later promoted to Instructor (2009) at Stanford University before he joined his current position (2010 - ). In addition to his award from STOP CANCER, he is the recipient of the NIH Pathway to Independence (PI) Award (K99/R00).


Year STOP CANCER Award was received: 2013 RCDA

Description of Research Performed: Dr. Chen’s research group is investigating the factors in the bone marrow microenvironment that help leukemia cells evade chemotherapy and the mechanisms used by leukemia cells to modulate the bone marrow microenvironment, such that they are supported in lieu of normal blood progenitor cells.


Results of Research: Dr. Chen’s group has established mouse models and cell culture systems to study the interactions between leukemia cells and the bone marrow microenvironment. The research will foster an improved understanding of cellular and molecular properties of the bone marrow microenvironment and how those factors promote leukemia initiation and progression. Results from the studies should suggest novel therapeutic strategies with which to target the malignant niche in order to provide better treatment options for patients with leukemia and other bone marrow metastases.

STOP CANCER is committed to funding the most promising and innovative scientists in their early research of all forms of cancer prevention, treatment, cures and subsequent clinical applications. STOP CANCER works primarily with local National Cancer Institute-designated Comprehensive Cancer Centers and other qualified institutions in the United States to carry out its mission.

Copyright © 2015 STOP CANCER. All Rights Reserved. | Privacy Policy